PKI Share Price

Open 71.96 Change Price %
High 72.62 1 Day 0.49 0.68
Low 71.79 1 Week 0.00 0.00
Close 72.32 1 Month 0.93 1.30
Volume 607879 1 Year 21.42 42.08
52 Week High 72.82
52 Week Low 49.72
PKI Important Levels
Resistance 2 73.09
Resistance 1 72.77
Pivot 72.24
Support 1 71.87
Support 2 71.55
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
GE 20.16 -1.22%
GE 20.16 -1.22%
GE 20.16 -1.22%
GE 20.16 -1.22%
GE 20.16 -1.22%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
TREX 109.45 25.65%
HZO 18.55 22.04%
SSD 55.74 14.62%
TBI 27.10 14.11%
SSTK 38.99 13.84%
KAI 113.60 13.09%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

PerkinElmer, Inc. (NYSE: PKI)

PKI Technical Analysis 5
As on 31st Oct 2017 PKI Share Price closed @ 72.32 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 61.35 & Strong Buy for SHORT-TERM with Stoploss of 68.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
PKI Target for November
1st Target up-side 74.37
2nd Target up-side 75.81
3rd Target up-side 77.25
1st Target down-side 70.27
2nd Target down-side 68.83
3rd Target down-side 67.39
PKI Other Details
Segment EQ
Market Capital 3584113920.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.perkinelmer.com
PKI Address
PKI
940 Winter Street
Waltham, MA 02451
United States
Phone: 781-663-6900
PKI Latest News
Interactive Technical Analysis Chart PerkinElmer, Inc. ( PKI NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PerkinElmer, Inc.
PKI Business Profile
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.